Search - tctmd.com

Displaying 41 - 60 of 363

Sort: Relevancy | Date

Presentation THT 2023

TR in the Modern Era: Natural History, Pathoanatomy, and Imaging

Presenter: Rebecca Hahn

March 22, 2023

Presentation THT 2023

The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients

Presenter: NULL

March 22, 2023

Presentation THT 2023

Long-term Outcomes of Endovascular Baroreflex Amplification in Symptomatic Patients With HFrEF

Presenter: JoAnn Lindenfeld

March 22, 2023

Presentation THT 2023

Physiological Modeling at Rest and Exercise of a Novel Right-to-Right Cardiac Shunt

Presenter: Greg Lewis

March 22, 2023

Presentation THT 2023

Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients With Pre Cardiogenic Shock

Presenter: Gad Cotter

March 22, 2023

Presentation THT 2023

Clinical Feasibility of a Novel Right-to-Right Cardiac Shunt in Pulmonary Hypertension using Off-the-Shelf Devices

Presenter: David Lim

March 22, 2023

Presentation THT 2023

Transcatheter Pulmonary Artery Banding in Chronic Heart Failure: Results From an Early Feasibility Study

Presenter: Sean Pinney

March 22, 2023

Presentation THT 2023

Does Obesity Paradox Exist in Cardiogenic Shock?

Presenter: Maya Guglin

March 22, 2023

Presentation THT 2023

No-Implant Interatrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Six-Month Outcomes From Multi-Center Pilot Feasibility Studies

Presenter: James Udelson

March 22, 2023

Presentation THT 2023

Avoiding Treatment In Hospital With Furoscix To Manage Congestion At Home: A Pilot Study

Presenter: Marvin Konstam

March 22, 2023

Presentation THT 2023

Heart Failure Management - Where do we go from here?

Presenter: Nir Uriel

March 21, 2023

Presentation THT 2023

HeartMate 3 LVAD beyond MOMENTUM 3 – Where are we now?

Presenter: Scott Silvestry

March 21, 2023

Presentation THT 2023

Contemporary outcomes for CardioMEMS HF System – What does this mean for pressure-guided heart failure management?

Presenter: JoAnn Lindenfeld

March 21, 2023

Presentation THT 2023

New LVAD's On the Horizon

Presenter: Francis Pagani

March 21, 2023

Presentation THT 2023

Blood Volume Analysis Guided Heart Failure Management: A Pilot Randomized Controlled Trial

Presenter: Marat Fudim

March 21, 2023

Presentation THT 2023

Exercise Capacity and Health-Related Quality of Life With Furoscix: Data From the AT HOME Pilot Study

Presenter: Marvin Konstam

March 21, 2023

Presentation THT 2023

Next Trials in LVAD Therapy

Presenter: Jerry Estep

March 21, 2023

Presentation THT 2023

Longer Term Effects of Hemodynamic Monitoring on Outcomes: A Combined Data Analysis of Patients with HFrEF in CHAMPION, GUIDE-HF, and LAPTOP-HF

Presenter: JoAnn Lindenfeld

March 21, 2023

Presentation THT 2023

Harnessing the Lymphatic System the Treat Heart Failure

Presenter: William Abraham

March 21, 2023

News Conference News THT 2023

Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF

Shelley Wood

March 21, 2023

Advertisement

TR in the Modern Era: Natural History, Pathoanatomy, and Imaging

The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients

Long-term Outcomes of Endovascular Baroreflex Amplification in Symptomatic Patients With HFrEF

Physiological Modeling at Rest and Exercise of a Novel Right-to-Right Cardiac Shunt

Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients With Pre Cardiogenic Shock

Clinical Feasibility of a Novel Right-to-Right Cardiac Shunt in Pulmonary Hypertension using Off-the-Shelf Devices

Transcatheter Pulmonary Artery Banding in Chronic Heart Failure: Results From an Early Feasibility Study

Does Obesity Paradox Exist in Cardiogenic Shock?

No-Implant Interatrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Six-Month Outcomes From Multi-Center Pilot Feasibility Studies

Avoiding Treatment In Hospital With Furoscix To Manage Congestion At Home: A Pilot Study

Heart Failure Management - Where do we go from here?

HeartMate 3 LVAD beyond MOMENTUM 3 – Where are we now?

Contemporary outcomes for CardioMEMS HF System – What does this mean for pressure-guided heart failure management?

New LVAD's On the Horizon

Blood Volume Analysis Guided Heart Failure Management: A Pilot Randomized Controlled Trial

Exercise Capacity and Health-Related Quality of Life With Furoscix: Data From the AT HOME Pilot Study

Next Trials in LVAD Therapy

Longer Term Effects of Hemodynamic Monitoring on Outcomes: A Combined Data Analysis of Patients with HFrEF in CHAMPION, GUIDE-HF, and LAPTOP-HF

Harnessing the Lymphatic System the Treat Heart Failure

Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content